A common IFI44L variant strongly predicts clinical trajectories in aging and neurodegeneration

Abstract

Background: Dysregulation of the interferon (IFN) response is emerging as a major pathobiological contributor across multiple forms of neurodegeneration, but much less is known about how genetic variation in the IFN pathway modulates the course of neurodegenerative disease.

The paper